SNX18P1Y

Across TCGA pan-cancer cohorts, SNX18P1Y RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SNX18P1Y’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SNX18P1Y RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNX18P1Y is over-expressed in tumor.

KIRC, LUSC, and LIHC are the cancer types where SNX18P1Y tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNX18P1Y RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	II,III,IV	+0.090	.004	8	view →
LUSC	All	All	+0.096	.014	3	view →
LIHC	All	All	+0.059	.003	3	view →
PRAD	All	All	+0.140	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SNX18P1Y–KIRC

Open the KIRC breakdown →